ReviewBlood neoplasia2026
Lineage switch in leukemia and lymphoma: case reports and molecular and cellular mechanisms.
Review in Blood neoplasia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leukemias and lymphomas may occasionally show phenotypic lineage switch (LS) upon relapse with retention of genotypic signatures from the initial neoplasm (before and after switch). Such cases of LS are historically and currently associated with exceedingly poor prognosis in both pediatric and adult patients. Instances of LS are increasingly recognized, notably in B-cell acute lymphoblastic leukemia after immunotherapy. Hypotheses of LS have historically included transdifferentiation, dedifferentiation, and/or common progenitor cells. Experimental models have further clarified the changes in gene expression and epigenetic remodeling which drive lymphoid-myeloid reprogramming. Summarized herein are a collection of such findings, particularly regarding the most common type of LS in patients, namely B-cell neoplasms with conversion to myeloid phenotypes ("B-myeloid conversion"). Additionally, a review of the literature of pediatric and adult case reports is included to help represent the disease characteristics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.